STATE OF THE ART
Although capillaroscopy was born in the 18th Century, when the Italian physician Giovanni Rasori (1766-1837) first noted the close relationship between conjunctival inflammation and the presence of an "inextricable knot of capillary loops" using a "magnifying glass," it was only in 1973 that Maricq and LeRoy published the first article describing the specific capillaroscopic pattern in SSc 2 .
However, for several decades thereafter capillaroscopy had difficulties to become an accepted and widely used diagnostic technique in SSc. Interestingly, a Medline search performed using the term "capillaroscopy" (retrieving a total of 759 articles from 1973 to today) revealed 22 These aspects of its evolution were discussed in a 2009 editorial supporting the growing need for nailfold capillaroscopy in rheumatology and suggesting the main reason for its limited past use: a lack of dissemination of its value in rheumatology circles 3 .
In fact, other reasons may account for the slow growth of the use of capillaroscopy, despite its being recognized from the beginning as the safest, most reliable tool for early diagnosis of SSc (i.e., by using it for the detection of scleroderma patterns).
CAPILLAROSCOPY AND CLASSIFICATION CRITERIA OF SYSTEmIC SCLEROSIS
An important issue is that for a long time, capillaroscopic findings of the scleroderma pattern were not included in the classification criteria of SSc, and only after 2000 were they introduced in published classification criteria 4, 5 . Interestingly, in 2001 the sensitivity of the American College of Rheumatology (ACR) criteria to identify patients with limited disease was found to be significantly improved with addition of nailfold capillary abnormalities and visible telangiectasias (from 34% to 89%) 6 . Recently, 101 patients with SSc were analyzed for the same purpose and, of these, 68 (67%) met ACR classification criteria 7 . However, the sensitivity increased from 67% to 99% with the addition of the nailfold capillary abnormalities identified using a simple dermatoscope and visible telangiectasias.
Further, a 20-year prospective study 8 was the first to validate criteria for early diagnosis of SSc, as proposed by LeRoy and Medsger in The Journal 9 , in which capillaroscopy was considered as an essential diagnostic tool. The study also confirmed the value of capillaroscopy to predict progression to definite SSc in patients with Raynaud's phenomenon (RP) with scleroderma-and/or SSc-specific antibodies.
More recently, after 3 Delphi rounds seeking expert opinion criteria for very early SSc and categorizing of their 121 items into 3 domains containing 7 items, it was suggested that abnormal capillaroscopy with scleroderma pattern showed the highest sensitivity and specificity together with RP and specific autoantibodies 10 . Clearly, all these investigations over the last decade have increased the interSee Learning curve in videocapillaroscopy, page 1248
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PATTERNS AND CAPILLAROSCOPY
Indeed, further strong support for the broader use of capillaroscopy arose from the recent validated description, definition, and scoring of the different scleroderma patterns using nailfold videocapillaroscopy (NVC) 11, 12, 13 . The presence of giant capillaries and microhemorrhages on NVC is now validated as sufficient to identify the early scleroderma pattern (early), whereas an increase in these features in addition to loss of capillaries identify the active pattern (active scleroderma pattern) and is followed by neoangiogenesis, fibrosis, and "desertification" (late scleroderma pattern; Figure 1 ). These patterns were described for the first time in The Journal 14 . Based on the appearance of the early NVC scleroderma pattern, almost 15% of patients move from primary to secondary RP over a mean followup period of 29.4 ± 10 months.
Recently, a 7-year longitudinal study involving patients with SSc with the early scleroderma NVC pattern demonstrated a dynamic transition of microvascular damage through the different NVC patterns of microangiopathy in almost 50% of patients 15 . In particular, the active scleroderma pattern was seen in 34%, the late scleroderma pattern in 13%, and a normal pattern in 5%. The mean time of progression from the early to the active pattern and from the early to the late pattern was 28 ± SD 20 months and 36 ± SD 29 months, respectively. Interestingly, clinical symptoms progressed in accordance with the nailfold morphologic changes in 60% of the patients with SSc. Recently, it was demonstrated that technical skill in NVC can quickly be attained by a short period of training; moreover, to implement learning and training in NVC in the rheumatic diseases an atlas/textbook has been published under the aegis of EULAR and the authorship of the most prominent world experts 16, 17 .
EDUCATION AND TRAINING IN CAPILLAROSCOPY
In a recent survey listing 14 tools for the diagnosis of 
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The Journal of on June 24, 2017 -Published by www.jrheum.org Downloaded from rheumatic diseases, participants, who were 170 young rheumatologists (113 trainees and 57 specialists, 33 ± 4.2 years of age) from 32 EULAR countries, considered capillaroscopy as the second most interesting tool for their future learning 18 . In particular, although actual knowledge of capillaroscopy was admitted in only 6.4% of those interviewed compared to 50% in ultrasound, for example, interest for further learning was 31% and 68.2% of participants, respectively, placing both tools at a superior level of interest, with capillaroscopy at the top, compared with all the other 14 tools 18 .
Indeed, the requirement in demonstrating competence in interpreting NVC abnormalities is now part of the "core curriculum" for rheumatologists in Europe.
In light of these growing facilities and opportunities to optimize "materials and methods" for the use of capillaroscopy, at least in SSc, the impressive growth of published studies in very recent years is a pleasant and expected consequence.
In particular, the recent study by Gutierrez, et al 1 providing evidence of a learning curve in interpreting nailfold capillary abnormalities and scleroderma pattern by NVC for inexperienced readers and achieving a good interreader agreement after one week of intensive training is a further important contribution.
Interestingly, in this educational program inexperienced readers were not able to discern the "normal" NVC pattern from the scleroderma patterns, suggesting that future programs will need to focus better on distinctions between normal and scleroderma patterns.
Notably, the issue of "normal" has always represented an enigma in medicine; however, in capillaroscopy the normal capillaroscopic pattern is simply a picture that does not show the major markers of disease and that qualifies the scleroderma patterns (namely, giant capillaries and related microhemorrhages, loss of capillaries, and angiogenesis). There exists also a series of morphological microvascular variations/abnormalities that represent an overlap between the range of normality and/or related to sequellae of local trauma. These abnormalities include mainly tortuosity, capillary crossing, bizarre capillaries, ectasias, skin transparency, and visibility of the subpapillary venous plexus, and localized posttraumatic microhemorrhages.
CLINICAL USE OF CAPILLAROSCOPY
Lastly, it seems that the most attractive reason for broaderbased learning and use of NVC is the assessed predictive value for progression of clinical complications of SSc, linked to the different NVC scleroderma patterns and including the scoring of severity.
Nailfold capillary density, for example, is associated with the presence and severity of pulmonary arterial hypertension in SSc or with progression of digital ulcers 19, 20, 21 .
In addition, by a more widespread employment of capillaroscopy, it should be possible to identify patients with SSc, for example, at different levels of severity of digital vascular disease, for recruitment into clinical trials in which capillaroscopy will be one of several or even the major outcome measure.
The right time for broader use of capillaroscopy is now: this is obvious because of the current availability of different drugs to test in clinical trials in SSc, the increased international networking of clinicians with an interest in RP, and the validation of the diagnostic value of NVC 22 .
In conclusion, capillaroscopy, particularly NVC, is a safe, noninvasive, and reliable tool that has recently gained an important role in early diagnosis, prediction of disease progression, and management of SSc. Further progression and optimization of the potentialities of nailfold videocapillaroscopy is linked to widespread training and education on its use. mAURIZIO CUTOLO, MD, 
